C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1997
12/29/1997	EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders
12/29/1997	EP0813425A1 Metal radionuclide labeled proteins for diagnosis and therapy
12/29/1997	EP0813422A1 Compositions and methods for stimulating antibody class switching
12/29/1997	EP0813419A1 Modulators of regulatory proteins
12/29/1997	EP0813364A1 Bacillus thuringiensis isolates active against weevils
12/29/1997	EP0672141A4 Methods of preparing soluble, oligomeric proteins.
12/29/1997	EP0642305B1 NOVEL BACILLUS THURINGIENSIS ISOLATE DENOTED B.t.PS158C2, ACTIVE AGAINST LEPIDOPTERAN PESTS, AND GENES ENCODING LEPIDOPTERAN-ACTIVE TOXINS
12/29/1997	EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides
12/29/1997	EP0631586B1 Amino procollagen 1(i) peptides
12/29/1997	EP0546096B1 Macrophage activating factor from vitamin d binding protein
12/28/1997	CA2206663A1 Peptides which bind to prothrombin and thrombin
12/24/1997	WO1997048983A1 SCREENING COMPOUNDS FOR THE ABILITY TO ALTER THE PRODUCTION OF AMYLOID-β PEPTIDE (x-≥41)
12/24/1997	WO1997048976A2 Method for discovering novel anthelmintic compounds
12/24/1997	WO1997048820A1 Promiscuous g-protein compositions and their use
12/24/1997	WO1997048819A1 Cassava vein mosaic virus promoters and uses thereof
12/24/1997	WO1997048813A2 Fibroblast growth factor receptor activating gene 1 (frag1). fgfr2-frag1 fusions
12/24/1997	WO1997048809A1 LIGASE ISOLATED FROM $i(MYCOBACTERIUM AVIUM)
12/24/1997	WO1997048808A1 Bacterial production of interferon-beta using low levels of sodium and potassium ions
12/24/1997	WO1997048807A1 CHEMOKINE β-15
12/24/1997	WO1997048806A1 Gene therapy for obesity
12/24/1997	WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF
12/24/1997	WO1997048804A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses
12/24/1997	WO1997048803A1 Human protein kinase c inhibitor homolog
12/24/1997	WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG
12/24/1997	WO1997048801A2 Polynucleotides encoding secreted proteins
12/24/1997	WO1997048800A1 Polynucleotides encoding secreted proteins from human pbmc
12/24/1997	WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins
12/24/1997	WO1997048798A1 Polynucleotide encoding secreted protein isolated from human dendritic cells
12/24/1997	WO1997048797A1 Novel human chromosome 16 genes, compositions, methods of making and using same
12/24/1997	WO1997048796A1 A method for determining susceptibility to insulin dependent diabetes mellitus
12/24/1997	WO1997048792A1 Transgenic non-human mammals with progressive neurologic disease
12/24/1997	WO1997048729A1 Bivalent molecules that form an activating complex with an erythropoietin receptor
12/24/1997	WO1997048728A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity
12/24/1997	WO1997048727A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus
12/24/1997	WO1997048725A1 Novel peptides for prevention and treatment of infection
12/24/1997	WO1997048724A2 Human metabotropic glutamate receptor
12/24/1997	WO1997048723A2 Ptp-20, pcp-2, bdp1, clk and sirp proteins and related products
12/24/1997	WO1997048721A1 Hodgkin's disease associated molecules and uses thereof
12/24/1997	WO1997048719A1 Pheromone compositions and methods of use in controlling fungal diseases in plants
12/24/1997	WO1997048419A1 Gene therapy for obesity
12/24/1997	WO1997048418A1 Improved method for treatment and diagnosis of il-5 mediated disorders
12/24/1997	WO1997048417A1 Vaccine to prevent streptococcal endocarditis
12/24/1997	WO1997048407A1 Substances for treating leptin pathway abnormalities
12/24/1997	WO1997048406A1 Rhesus monkey neuropeptide y y2 receptor
12/24/1997	WO1997048370A2 Vaccines comprising synthetic genes
12/24/1997	WO1997048275A1 Endoderm, cardiac and neural inducing factors
12/24/1997	WO1997044456A3 Tumor virus susceptibility genes and gene products, and uses related thereto
12/24/1997	WO1997043314A3 Collagen binding protein compositions and methods of use
12/24/1997	WO1997041235A3 A NEW, PIGMENT-PRODUCING, STRAIN OF $i(BACILLUS THURINGIENSIS)
12/24/1997	WO1997041230A3 Cc-type chemokines
12/24/1997	WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations
12/24/1997	WO1997039122A3 Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof
12/24/1997	WO1997033909A3 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
12/24/1997	CN1168699A Protein kinase NPK-llo
12/24/1997	CN1168698A Recombinant proteins of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines
12/24/1997	CN1168697A Rantes peptide and fragments and compositions comprising it for treatment of inflammation
12/24/1997	CN1168695A Inhibitor of stem cell proliferation and uses thereof
12/24/1997	CN1168678A Method of treating diabetes mellitus using KGF
12/24/1997	CN1168677A Novel peptides derived from autoantigent for use in immunotherapy of autoimmune diseases
12/24/1997	CN1168676A Materials for the production of nanometer structures and use thereof
12/24/1997	CN1168674A Synthetic peptides and vaccines comprising same
12/24/1997	CN1168635A New antithrombotic formulation, process for its manufacturing, and use thereof
12/24/1997	CN1168413A Erythropoietin
12/24/1997	CA2294433A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus
12/24/1997	CA2259122A1 Novel ptp-20, pcp-2, bdp1, clk and sirp proteins and related products and methods
12/24/1997	CA2258789A1 Endoderm, cardiac and neural inducing factors
12/24/1997	CA2258755A1 Gene therapy for obesity
12/24/1997	CA2258573A1 Hodgkin's disease associated molecules and uses thereof
12/24/1997	CA2258568A1 Vaccines comprising synthetic genes
12/24/1997	CA2258526A1 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses
12/24/1997	CA2258515A1 Improved method for treatment and diagnosis of il-5 mediated disorders
12/24/1997	CA2258507A1 Chemokine beta-15
12/24/1997	CA2258504A1 Gene therapy for obesity
12/24/1997	CA2258011A1 Vaccine to prevent streptococcal endocarditis
12/24/1997	CA2257855A1 Human thymosin .beta.15 gene, protein and uses thereof
12/24/1997	CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins
12/24/1997	CA2257842A1 Polynucleotides encoding secreted proteins from human pbmc
12/24/1997	CA2257834A1 Polynucleotides encoding secreted proteins
12/24/1997	CA2257827A1 Polynucleotide encoding secreted protein isolated from human dendritic cells
12/24/1997	CA2257528A1 Human protein kinase c inhibitor homolog
12/24/1997	CA2257130A1 Human camp-dependent protein kinase inhibitor homolog
12/24/1997	CA2256486A1 Novel human chromosome 16 genes, compositions, methods of making and using same
12/24/1997	CA2246751A1 Human metabotropic glutamate receptor
12/23/1997	US5700928 Polynucleotide encoding saliva binding protein
12/23/1997	US5700927 Tbc1 gene and uses thereof
12/23/1997	US5700926 Isolated nucleic acid which codes for a human gene and can be used as a vector for gene expression in cell cultures, also for diagnosis of a congenital defect
12/23/1997	US5700925 DNA encoding stationary phase, stress response sigma factor from Mycobacterium tuberculosis
12/23/1997	US5700924 Serpin derived from human hypothalamus
12/23/1997	US5700922 PNA-DNA-PNA chimeric macromolecules
12/23/1997	US5700915 Human interleukin immunopurification processes
12/23/1997	US5700914 Preventing activation(and degradation) of blood coagulation factor vii(in solution) during repeated chromatography cycles with zinc ions present in the solution
12/23/1997	US5700913 Unglycosylated human interleukin-2 polypeptides
12/23/1997	US5700911 Bone morphogenetic protein -11 (BMP-11) compositions
12/23/1997	US5700910 N-acyl-S-(2-hydroxyalkyl) cysteines, their preparation and their use as intermediates for the preparation of synthetic immuno-adjuvants and synthetic vaccines
12/23/1997	US5700909 For stimulating neural cell outgrowth
12/23/1997	US5700908 For preparation of anti-integrin antibodies for detection and quantitation of integrins by immunoassay
12/23/1997	US5700907 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
12/23/1997	US5700906 Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
12/23/1997	US5700905 Hexapeptides, cyclic peptides; as binding g-protein-linked receptors
12/23/1997	US5700904 Preparation of an acylated protein powder

1 ... 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 ... 2916